Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers-Reference-Cited by-同舟云学术

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers

Published:2011-10 Issue:1 Volume:74 Page:139-144
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Tomizawa Kenji,Suda Kenichi,Onozato Ryoichi,Kosaka Takayuki,Endoh Hideki,Sekido Yoshitaka,Shigematsu Hisayuki,Kuwano Hiroyuki,Yatabe Yasushi,Mitsudomi Tetsuya

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment;Normanno;Endocr Relat Cancer,2003

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry;Pellegrini;Clin Cancer Res,2003

4. Trastuzumab in the treatment of advanced non-small-cell lung cancer: is there a role? Focus on eastern cooperative oncology group study 2598;Langer;J Clin Oncol,2004

5. Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas;Hirsch;Br J Cancer,2002

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a pyrotinib-based regimen in non-small cell lung cancer patients harboring HER2 alterations: A real-world retrospective study;Journal of Cancer Research and Therapeutics;2023-12

2. Exploring the correlation between HER2 alterations and 18F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer patients;Journal of Cancer Research and Clinical Oncology;2023-08-12

3. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies;MedComm;2023-07-10

4. Perspective Chapter: Molecular Pathology of Lung Cancer;Molecular Histopathology and Cytopathology;2023-06-14

5. A Comprehensive Review on the Role of Human Epidermal Growth Factor Receptor 2 (HER2) as a Biomarker in Extra-Mammary and Extra-Gastric Cancers;Onco;2023-05-26